CD3+/CD4+ cells combined with myosteatosis predict the prognosis in patients who underwent gastric cancer surgery.

Zhongze DuYouming XiaoGuiming DengHaibin SongYingwei XueHongjiang Song

Published in: Journal of cachexia, sarcopenia and muscle (2024)

Lymphocyte subsets, including CD3+/CD4+ cells, CD4+/CD8+ ratio and CD19+ cells, are indicative of clinical prognosis in gastric cancer surgery patients. Body composition parameters, such as sarcopenia and myosteatosis, are also associated with the patient's prognosis. The combination of CD3+/CD4+ cells with myosteatosis demonstrates enhanced prognostic value, enabling the identification of patients at high risk of post-operative metastasis and recurrence.

Keyphrases

induced apoptosis
body composition
cell cycle arrest
end stage renal disease
minimally invasive
newly diagnosed
ejection fraction
chronic kidney disease
endoplasmic reticulum stress
oxidative stress
cell death
peritoneal dialysis
resistance training
patient reported
surgical site infection